Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$2.20
-3.1%
$2.45
$2.10
$5.20
$234.12M1.27613,867 shs912,311 shs
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
$0.41
$0.41
$0.01
$0.44
$66.04M0.67140,659 shsN/A
OptimizeRx Co. stock logo
OPRX
OptimizeRx
$14.27
-5.2%
$10.69
$3.78
$15.71
$263.92M1.34295,033 shs203,676 shs
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
$3.25
-0.9%
$2.66
$2.17
$4.35
$254.50M0.3156,246 shs197,466 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
MaxCyte, Inc. stock logo
MXCT
MaxCyte
0.00%+2.33%-1.35%-33.13%-56.00%
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
0.00%0.00%0.00%0.00%0.00%
OptimizeRx Co. stock logo
OPRX
OptimizeRx
0.00%-2.39%+33.99%+83.66%+21.97%
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
0.00%+4.50%+24.52%+12.07%+324,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.5871 of 5 stars
3.55.00.00.02.02.51.3
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
N/AN/AN/AN/AN/AN/AN/AN/A
OptimizeRx Co. stock logo
OPRX
OptimizeRx
2.2037 of 5 stars
2.44.00.00.03.41.70.6
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.00
Buy$7.50240.91% Upside
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
0.00
N/AN/AN/A
OptimizeRx Co. stock logo
OPRX
OptimizeRx
2.73
Moderate Buy$10.81-24.23% Downside
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
4.00
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest OMCM, OPRX, MXCT, and PHLT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.50 ➝ $16.00
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $12.50
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$11.00 ➝ $14.00
(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$37.68M6.21N/AN/A$2.23 per share0.99
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
$27.10M2.44$0.03 per share14.62($0.07) per share-5.86
OptimizeRx Co. stock logo
OPRX
OptimizeRx
$94.37M2.80N/AN/A$6.97 per share2.05
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
$128.92M1.97N/AN/A$1.05 per share3.10
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$37.92M-$0.40N/AN/AN/A-78.36%-16.00%-13.93%8/5/2025 (Estimated)
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
$3.69MN/A0.00N/A-2.67%-13.18%-6.95%N/A
OptimizeRx Co. stock logo
OPRX
OptimizeRx
-$17.57M-$0.84N/AN/AN/A-27.41%-4.92%-3.41%8/6/2025 (Estimated)
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
-$7.52M-$0.08N/AN/AN/A-6.74%-10.19%-7.83%8/6/2025 (Estimated)

Latest OMCM, OPRX, MXCT, and PHLT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q1 2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
-$0.11$0.08+$0.19-$0.12$18.69 million$21.93 million
5/8/2025Q1 2025
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
-$0.02$0.02+$0.04N/A$29.92 million$33.27 million
5/7/2025Q1 2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$0.10-$0.10N/A-$0.10$9.05 million$10.39 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/AN/AN/AN/AN/A
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
N/AN/AN/AN/AN/A
OptimizeRx Co. stock logo
OPRX
OptimizeRx
N/AN/AN/AN/AN/A
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/A
9.81
9.22
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
N/A
0.51
0.51
OptimizeRx Co. stock logo
OPRX
OptimizeRx
0.29
3.23
3.23
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
0.11
2.67
2.67

Institutional Ownership

CompanyInstitutional Ownership
MaxCyte, Inc. stock logo
MXCT
MaxCyte
68.81%
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
N/A
OptimizeRx Co. stock logo
OPRX
OptimizeRx
76.47%
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
77.15%

Insider Ownership

CompanyInsider Ownership
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.30%
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
48.90%
OptimizeRx Co. stock logo
OPRX
OptimizeRx
5.60%
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
9.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
MaxCyte, Inc. stock logo
MXCT
MaxCyte
80106.42 million102.67 millionOptionable
OmniComm Systems, Inc. stock logo
OMCM
OmniComm Systems
175161.07 millionN/ANot Optionable
OptimizeRx Co. stock logo
OPRX
OptimizeRx
10018.50 million17.30 millionOptionable
Performant Healthcare, Inc. - Common Stock stock logo
PHLT
Performant Healthcare, Inc. - Common Stock
93078.31 million71.09 millionN/A

Recent News About These Companies

PHLT Performant Healthcare, Inc.
Performant Healthcare: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

MaxCyte stock logo

MaxCyte NASDAQ:MXCT

$2.20 -0.07 (-3.08%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$2.21 +0.01 (+0.41%)
As of 06/13/2025 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

OmniComm Systems stock logo

OmniComm Systems OTCMKTS:OMCM

$0.41 0.00 (0.00%)
As of 10/11/2019

OmniComm Systems, Inc., a healthcare technology company, provides Web-based electronic data capture (EDC), and eClinical software and services for pharmaceutical and biotechnology companies, clinical research organizations (CROs), and other clinical trial sponsors worldwide. It offers TrialMaster, which allows organizations conducting clinical trials to collect and manage the data over the Internet; TrialOne Phase I Clinic Automation, a software application suite that provides clinical trial site sponsors, study investigators, and study monitors with various tools to conduct the Phase I clinic operation; and IRTMaster, which offers interactive response technology in support of the randomization process in clinical trials. The company also provides eClinical Suite that comprises a set of tools for collecting and managing clinical data, including EDC for real-time entry and double data entry (DDE) for entry from paper originals; and Promasys, a clinical trial data management system for DDE and EDC, which is primarily used at research institutions for investigator-initiated trials. In addition, it offers Acuity, a clinical data aggregation and analytics platform that provides actionable insights into quality, risk, and performance of various aspects of clinical trials in real time. Further, the company provides consulting and professional services, such as project management, clinical services, training, custom configuration, system integration, standard operating procedures and implementation assistance, installation, and validation services, as well as application hosting and related support services. It sells its products through a direct sales force and relationships with CRO partners, as well as through co-marketing agreements with vendor and channel partners. OmniComm Systems, Inc. was founded in 1996 and is headquartered in Fort Lauderdale, Florida.

OptimizeRx stock logo

OptimizeRx NASDAQ:OPRX

$14.27 -0.78 (-5.18%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$14.18 -0.08 (-0.60%)
As of 06/13/2025 07:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Performant Healthcare, Inc. - Common Stock stock logo

Performant Healthcare, Inc. - Common Stock NASDAQ:PHLT

$3.25 -0.03 (-0.91%)
As of 06/13/2025 04:00 PM Eastern

Performant Healthcare, Inc. engages in the provision of technology-enabled audit, recovery, customer care, and related analytics services. Its services help identify improper payments, and in some markets, restructure and recover delinquent or defaulted assets and improper payments for both government and private clients. The company was founded in 1976 and is headquartered in Plantation, FL.